期刊文献+

重组质粒pYTA/Aβ-HBcAg的构建及其在大肠杆菌中的表达 被引量:2

Construction of recombinant plasmid pYTA/Aβ-HBcAg and its expression in E.coli
下载PDF
导出
摘要 目的 :研究 β 淀粉样肽 (Aβ)与HBcAg的融合基因Aβ HBcAg的原核表达 ,并检测表达的融合蛋白Aβ HBcAg的免疫原性。方法 :从重组质粒 7Z/Aβ HBcAg中 ,切下含Aβ HBcAg的基因片段 ,将其融合于质粒pYTA1的lac启动子之后 ,构建重组表达质粒pYTA/Aβ HBcAg。以此重组质粒转化大肠杆菌DH5α,在IPTG诱导下表达。超声破碎表达的细菌 ,通过SDS PAGE及考马斯亮蓝染色 ,检测融合蛋白Aβ HBcAg的表达。采用ELISA法检测融合蛋白的反应原性。融合蛋白经饱和硫酸铵盐析法分离和纯化后免疫BALB/c小鼠 ,用ELISA法检测血清中抗 Aβ抗体的滴度。 结果 :融合蛋白以可溶性形式存在于细菌裂解液的上清中 ,其表达量为菌体总蛋白量的 7%。表达的融合蛋白既有Aβ的反应原性 ,又有与HBcAg的反应原性。经 3次免疫后 ,BALB/c小鼠血清中抗 Aβ抗体的滴度最高可达为 1∶16 0 0 0。结论 :融合基因Aβ HBcAg可在大肠杆菌DH5α中表达。表达产物为可溶性蛋白 ,存在于细菌裂解液的上清中 ,具有较强的免疫原性。 AIM: To study the expression of fusion gene Aβ-HBcAg in E.coli and detect the immunogenicity of fusion protein Aβ-HBcAg. METHODS: The Aβ-HBcAg fusion gene was cut from recombinant plasmid pBV220/Aβ-HBcAg, and was inserted into the plasmid pYTA1 to construct recombinant plasmid pYTA/Aβ-HBcAg. The recombinant plasmid was transformed into E.coli DH5α, and expressed under IPTG induction. The expression of the fusion protein Aβ-HBcAg was detected by SDS-PAGE. The antigenicity of the fusion protein was detected by ELISA. BALB/c mice were immunized intraperitoneally with the fusion protein purified by salting out with saturate ammonium sulfate. The titers of anti- Aβ antibodies of the immunized mice was evaluated by ELISA. RESULTS: Fusion protein existed in supernatant of the bacteria lysate and its expression level was about 7% of the total bacteria protein. The fusion protein reacted with both Aβ and HBcAg. The highest titer of anti-Aβ antibodies could reach to 1∶16 000 after immunization for 3 times. CONCLUSION: Recombinant gene Aβ-HBcAg can be expressed in E.coli DH5α. The expression protein exists in supernatant of the bacteria lysate and has good immunogenicity. This study lays the foundation for the experimental animal study of AD gene-engineering vaccine.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第6期671-674,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 陕西省自然科学基金资助项目 (No .2 0 0 1SM57) 西安交通大学科学研究基金资助 (No .2 0 0 2 0 0 3)
关键词 阿尔茨海默病 Β-淀粉样肽 HBCAG 免疫原性 疫苗 Alzheimer’s disease β-amyloid peptide HBcAg antigenicity vaccine
  • 相关文献

参考文献9

  • 1Younkin SG. The role of Abeta 42 in Alzheimer ' s disease[J]. J Physiol, 1998, 92: 289-292.
  • 2Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature, 1999, 400(6740): 173-177.
  • 3Janus C, Pearson J, McLaurin J, et al. Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer ' s disease[J]. Nature, 2000, 498: 979-982.
  • 4Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer ' s disease[J]. Nat Med, 2000, 6(8): 916-919.
  • 5Alon M, Ruth M, Victor Z, et al. Immune hyporesponsiveness to amyloidβ-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer ' s disease[J]. Proc Natl Acad Sci USA, 2001, 98(18): 10273-10278.
  • 6Selkoe DJ. Alzheimer ' s disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein[J]. J Alzheimer ' s Disease, 2001, 3: 75-81.
  • 7胡金家,汪华侨,曲怀刚,徐杰,姚志彬.Aβ_(42)及亚单位疫苗诱导小鼠抗体产生及其中和Aβ_(42)的细胞毒性[J].细胞与分子免疫学杂志,2004,20(2):178-181. 被引量:29
  • 8冯改丰,胡海涛,刘中华,王全颖,杨广笑.β-淀粉样肽与乙型肝炎核心抗原融合基因Aβ-HBcAg表达载体的构建[J].西安交通大学学报(医学版),2003,24(1):9-13. 被引量:4
  • 9胡海涛 ,冯改丰 ,董炜疆 ,王全颖 ,杨广笑 .融合基因Aβ-HBcAg的原核表达及表达蛋白的免疫反应性和免疫原性分析[J].西安交通大学学报(医学版),2004,25(3):220-222. 被引量:6

二级参考文献25

  • 1李光地,汪滨,陈作义,汪垣,龚岳亭.HCG抗原决定簇与乙肝病毒核心抗原的融合表达[J].生物化学与生物物理学报,1996,28(2):177-186. 被引量:6
  • 2颜子颖 王海林.精编分子生物学实验指南[M].北京:科学出版社,1998.17-287.
  • 3金冬雁 黎孟枫.分子克隆实验指南.第2版[M].北京:科学出版社,1992.19-59.
  • 4Schenk D, Barbour R, Dunn W, et al. Immunization with amyloidbeta attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature, 1999, 400(6740): 173 - 177.
  • 5Arendash GW, Gordon MN, Diamond DM, et al. Behavioral assessment of Alzheimer' s transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition andspatial memory [ J]. DNA Cell Biol, 2001, (11): 737 -744.
  • 6Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the endof the beginning [J]. Nat Rev Neurosci, 2002, 3(10): 824 -828.
  • 7Ott G. The adjuvant MF59: the 1998 perspective, clinical, persormanceand mechanism of action [J]. Res immunol, 1998, 149:25 -27.
  • 8J Mclaurin R, Cecal ME, Kierstead, et al. Therapeutically effectiveantibodies against amyliod-β residues 4-10 and inhibit cytotoxity andfibrillogenesis [ J ]. Nat Med, 2002, 8 ( 11 ): 1263 - 1269.
  • 9Ott G, Barchfeld GL, Van Nest G, et al. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59 [J]. Vaccine, 1995, 13(16): 1557-1562.
  • 10Plduslo JF, Cunan GL. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brainbarrier [J]. Neuroreport, 2001, 12(15): 3197-3200.

共引文献33

同被引文献20

  • 1胡海涛 ,冯改丰 ,董炜疆 ,王全颖 ,杨广笑 .融合基因Aβ-HBcAg的原核表达及表达蛋白的免疫反应性和免疫原性分析[J].西安交通大学学报(医学版),2004,25(3):220-222. 被引量:6
  • 2冯改丰,胡海涛,李月英,韩华,王全颖,杨广笑.重组基因c-Aβ-c的构建及其表达蛋白的免疫原性分析[J].细胞与分子免疫学杂志,2005,21(5):533-537. 被引量:8
  • 3叶廷安 詹美云.通过乙型肝炎病毒核心基因5'端的修饰使核心抗原在大肠杆菌中高效表达[J].病毒学报,1988,4:312-318.
  • 4Schodel F, Moriarty AM, Peterson D, et al. The position ofheterologous epitopes inserted in hepatitis B virus core particlesdetermines their immunogenicity[J]. J Virol, 1992, 66(1): 106-114.
  • 5Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-betaattenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature,1999, 400 (6740): 173-177.
  • 6Janus C, Pearson J, McLaurin J, et al. Abeta peptide immunizationreduces behavioural impairment and plaques in a model of Alzheimer'sdisease[J]. Nature, 2000, 408(6815): 979-982.
  • 7Selkoe DJ. Alzheimer's disease results from the cerebral accumulationand cytotoxicity of amyloid β-protein[J]. J Alzheimer's Disease, 2001, 3:75-81.
  • 8Selkoe DJ. The molecular pathology of Alzheimer's disease[J]. Neuron,1991, 6: 487-489.
  • 9Alon M, Ruth M, Victor Z, et al. Immune hyporesponsiveness to amyloidβ-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease[J]. Proc Natl AcadSci USA, 2001, 98(18): 10273-10278.
  • 10Morgan D,Diamond DM,Gottschall PE,et al.A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.Nature,2000;408(6815):982-985.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部